Amplimmune, Inc.

Promethera Biosciences SA NV has appointed Henrik L. Luessen chief business officer (CBO), Nancy Veulemans vice president clinical & medical affairs and Decebal Bora vice president regul

Money flowed to startups around the world in 2016 at a pace similar to 2015, providing for a steady stream of new companies to fill an important part of the biopharma ecosystem, and global venture cap

GenVec, a clinical-stage biopharmaceutical company focused on using its adenovector gene delivery platform to develop a pipeline of therapeutics and vaccines, has named Michael Richman to its board of

The profound achievements of the pharma, biotech and allied industries were celebrated last night at the annual Scrip Awards in London. In a glittering ceremony hosted by comedian Milton Jones, excell